Create a free Feed Strategy account to continue reading

Controlling coccidiosis in poultry for 50 years

Elanco product has helped control coccidiosis in poultry for 50 years.

Coccidiosis is a health challenge throughout the life of a bird and a major cause for performance and productivity losses for poultry producers. Nearly all flocks suffer from some form of coccidiosis caused by different types of Eimeria (E. acervulina, E. brunetti, E. maxima, E. necatrix and E. tenella).1 When not managed properly, coccidia can cause extensive intestinal damage, predisposition to secondary infections and potential mortality in chickens and turkeys.  

Fifty years ago, most broiler producers relied on management practices centered on hygiene and synthetic chemicals when signs of disease emerged. These practices were ineffective due to high challenge and built-up resistance. The introduction of Coban (monensin) 50 years ago by Elanco — as a division of Eli Lilly and Company (now
Elanco Animal Health) — transformed how producers controlled coccidiosis in chickens and turkeys with the use of coccidiostat ionophores. This breakthrough product continues to be key in overall poultry health and welfare in flocks across the United States.

“Before the introduction of Coban, producers relied mostly on treatments when they saw outbreaks, which in many cases was too late, creating devastating losses for their flocks,” said Cynthia Sanchez-McCormack, senior advisor, Global Poultry Intestinal Integrity Leader at Elanco Animal Health. 

Poultry production, as it is known today, dramatically increased in scale with the introduction of ionophores. “It also led to the discovery of so much more in the control of coccidiosis, including additional ionophores and antiprotozoals, paving the way for modern poultry production as we know it today,” said Sanchez-McCormack.